Based on the above observations, it could be concluded that ImI-modified micelles may be a potential targeted drug delivery system for α7-nAChR overexpressed NSCLC by enhancing the intracellular uptake of hydrophobic anticancer drugs. This evidence concerns the gene CHRNA7 and non-small cell lung carcinoma.